Chymase inhibitor TY-51469 in therapy of inflammatory bowel disease

doi:10.3748/wjg.v22.i5.1826

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8654)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

504

WORD

220

HTML

3696

Figures (1-2)

279

Tables (1-2)

215

Sum=4914

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1171

Download

2569

Sum=3740

Feb 7, 2016 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Feb 7, 2016; 22(5): 1826-1833
Published online Feb 7, 2016. doi: 10.3748/wjg.v22.i5.1826

Table 2 Serum levels of interleukin-10, transforming growth factor-β1 and interleukin-17A

Group	n	IL-10 (pg/mL)	TGF-β1 (pg/mL)	IL-17a (pg/mL)
Experiment	5	98.79 ± 3.45^a^c	59.23 ± 2.01^a^c	67.82 ± 3.25^a^c
Model	5	34.56 ± 5.78	23.45 ± 3.68	14.35 ± 2.46
Control	5	143.35 ± 2.35	68.56 ± 3.59	76.28 ± 3.56

^aP < 0.05 vs model group;

^cP < 0.05 vs control group. The results are shown as mean ± SD. IL: Interleukin; TGF: Transforming growth factor.

Citation: Liu WX, Wang Y, Sang LX, Zhang S, Wang T, Zhou F, Gu SZ. Chymase inhibitor TY-51469 in therapy of inflammatory bowel disease. World J Gastroenterol 2016; 22(5): 1826-1833
URL: https://www.wjgnet.com/1007-9327/full/v22/i5/1826.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i5.1826